Autoimmune Pancreatitis Presenting a Short Narrowing of Main Pancreatic Duct with Subsequent Progression to Diffuse Pancreatic Enlargement over 24 Months; Natural History of Autoimmune Pancreatitis
DOI:
https://doi.org/10.6092/1590-8577/2393Keywords:
Autoimmune Diseases, Cholangiopancreatography, Endoscopic Retrograde, Magnetic Resonance, Natural History, Neoplasms, Cystic, Mucinous, and Serous, Pancreatitis, Tomography, X-Ray ComputedAbstract
Context Initial pancreatogram and natural history of autoimmune pancreatitis (AIP) have not been clarified, and there were few recent studies concerning the association between AIP and intraductal papillary mucinous neoplasm (IPMN). Case report We report an 81-year- old man with AIP associated with IPMN. Although the initial pancreatogram was normal, a short narrowing of the main pancreatic duct (MPD) appeared during a follow-up for IPMN after 6 months, which was highly suggestive of pancreatic cancer. A narrowing of the MPD extended after 15 months, and this progressed to diffuse narrowing of the MPD with an elevation in the serum IgG4 levels after 24 months. Finally, the patient was diagnosed with diffuse-type AIP, according to the Japanese diagnostic criteria 2011 and the International Consensus Diagnostic Criteria. Considering the natural history of AIP, this marked change of the MPD is indicative of this condition. Conclusion We report a case of AIP presenting with a short narrowing of the MPD with subsequent progression to diffuse pancreatic enlargement during a follow-up for IPMN.
Image: Remarkable change of main pancreatic duct.
Downloads
References
Okazaki K, Uchida K, Matsushita M, Takaoka M. Autoimmune pancreatitis. Intern Med 2005; 44:1215-1223. [PMID: 16415540].
The Japan Pancreatic Society and Research Committee of Intractable Diseases of the Pancreas. Clinical diagnostic criteria for autoimmune pancreatitis 2011. J Jpn Pancreas Soc 2012; 27:17-25.
Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino- Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40:352-358. [PMID: 21412117].
Naitoh I, Nakazawa T, Notohara K, Miyabe K, Hayashi K, Shimizu S, et al. Intraductal papillary mucinous neoplasm associated with autoimmune pancreatitis. Pancreas 2013; 42:552-554. [PMID: 23486370].
Tabata T, Kamisawa T, Hara S, Kuruma S, Chiba K, Kuwata G, et al. Intraductal papillary mucinous neoplasm of the pancreas and IgG4- related disease: a coincidental association. Pancreatology 2013; 13:379-
[PMID: 23890136].
Bateman AC, Culver EL, Sommerlad M, Chetty R. Intraduct papillary mucinous neoplasm of the pancreas: a tumour linked with IgG4-related disease? J Clin Pathol; 2013: 66:671-675. [PMID: 23596150].
Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2102; 12:183-197. [PMID:
.
Manfredi R, Graziani R, Cicero C, Frulloni L, Carbognin G, Mantovani W, et al. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 2008; 247:435-443. [PMID: 18430876].
Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del Castillo C. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 2009; 250:118-29. [PMID: 19017924].
